Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Accessed 11/5/25
10.1016/S0140-6736(19)31271-1 Summary Keywords colorectal cancer, gastrointestinal cancer, GLP-1 receptor agonists, liver cancer, meta-analysis, obesity, oncological safety, pancreatic cancer Citation Wali AF, Rangraze I, Khan S, Mufti UB, El-Tanani M and Rizzo M (2026) Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies
Once optimal levels are reached, maintenance sessions may be scheduled every 2 to 4 weeks
Williams and Ro will lead a multi-year campaign to normalize the use of GLP-1 medications for weight loss and support others on their health journeys
I want to reiterate the governors commitment that the work wont stop here, Dana Sullivan, the boards designee from the Executive Office for Administration and Finance, said
2019;317:C13249
US$ 25.74
US$ 26.45
US$ 20.54
US$ 28.22
